Vyne Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Vyne Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Vyne Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vyne Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $5.6k | 3.4k | 1.65 |
| 2024-12-31 | $14k | 4.3k | 3.35 |
| 2024-09-30 | $3.4k | 1.8k | 1.88 |
| 2024-06-30 | $3.5k | 1.8k | 1.97 |
| 2024-03-31 | $5.7k | 1.9k | 3.07 |
| 2023-12-31 | $4.4k | 1.9k | 2.33 |
| 2023-09-30 | $8.8k | 2.2k | 4.04 |
| 2023-06-30 | $9.1k | 2.2k | 4.10 |